This study develops and validates an efficient, sensitive and simple method for the simultaneous determination of cetirizinedihydrochloride and pseudoephedrinecombined in tablet dosage form by high performance liquid chromatography (HPLC) with an ultraviolet (UV) detector.The validation of this method was carried out according to ICH and USP guidelines. In this study, the mobile phase used wasacetonitrile: water (530:470 (v/v)) with 200mg sodium heptane sulfonic acid and the pH value was adjusted to 2.5 with sulfuric acid. The limit of detection and quantification for cetirizinedihydrochloride were 0.805 and 2.685 µg/mL,respectively,and the limit of detection and quantification for pseudoephedrinewere17.976 and 59.921 µg/mL, respectively. The linearity was studied in the concentration range of 12.2 and 36.5 µg/mL forcetirizinedihydrochloride and 295.91 and 861.73 µg/mL for pseudoephedrine. The recovered amounts of cetirizinedihydrochloride and pseudoephedrinewere98.2% -102.9% and99.5%-102.4%, respectively.
INTRODUCTION
Cetirizine (CET) (Figure 1-A) is the carboxylated metabolite of hydroxyzine, and it has a high specific affinity for histamine H1 receptors. 1 Pseudoephedrine (PSE) (Figure 1-B) is a sympathomimetic drug that acts directly on alpha-adrenergic receptors. 2 The combination of pseudoephedrine and cetirizine with a long acting antihistaminic and slow release pseudoephedrine, which is a sympathomimetic,is a decongestant widely used in the comprehensive management of allergic rhinitis.
Cetirizine is a relatively new second-generation antihistamine in the market. It has, however, been foundthat cetirizine has both sedative and anti-cholinergic effects, though to a smaller extent than that seen in the first generation antihistamines. 4 A literature survey reveals a variety of analytical methods for the analysis of cetirizine and pseudoephedrine.A rapid, selective, and stable methodindicating high performance thin layer chromatography was developed and validated by Makhijaet al.for the simultaneous estimation in pharmaceutical dosage forms. The method employed TLC aluminum plates pre-coated with silica gel 60F-254 as the stationary phase. The solvent system consisted of ethyl acetate-methanol-ammonia (7:1.5:1, v/v/v). Tan et al. presented a liquid chromatography-ion trap mass spectrometry method coupled with electrospray ionization (HPLC-ESI-ion trap mass spectrometry) for simultaneous determination ofcetirizineandpseudoephedrinein human plasma. 6 A liquid chromatography/tandem mass spectrometry (LC/MS/MS) method was developed and evaluated to determine simultaneously the concentrations ofpseudoephedrine andcetirizinein human plasma. The procedure is only a one-step protein precipitation. 7 A dissolution test for a once daily combination tablet containing 10 mg ofcetirizine dihydrochloride (cetirizine HCl) for immediate release and 240 mg ofpseudoephedrinehydrochloride (pseudoephedrine HCl) for extended release was developed and validated by Likaret al.according to ICH and FDA guidelines. 8 A reversed-phase HPLC method and subsequent validation using an ICH suggested approach for the determination of antihistaminic-decongestant pharmaceutical dosage forms containing binary mixtures ofpseudoephedrinehydrochloride (PSE) with fexofenadine hydrochloride (FEX) orcetirizinedihydrochloride (CET) was developed by Karakuşet al.
9
A stability-indicating reversed-phase highperformance liquid chromatography (RP-HPLC) method has been developed by Hadadet al.The method can separate quantitiesof paracetamol, dantrolene,cetirizine,andpseudoephedrine. The method was validated for the purpose of conducting stability studies in quality control (QC) laboratories. Quantitation was achieved with UV detection at 214 nm, based on a peak area. 10 Moreover, other authors proposed amethod to determinepseudoephedrine hydrochloride (PSE) and cetirizinein plasma to investigate the pharmacokinetics profile.
11 A reversed phase high performance liquid chromatographic method was developed using a Shimadzu HPLC-VP series, LC-10 ATV pump, SPD10 AVP, and C8 column, for simultaneous determination of pseudoephedrine hydrochloride and cetirizine hydrochloride in 3 marketed tablet formulations (extended release). The mobile phase consistedof a phosphate buffer of pH 7.0 and acetonitrile HPLC grade in the ratio of 1:1. The flow rate was maintained at 1 mL/min, and the UV detection was done at 242 nm, which is the isosbestic point.
12
Zarapkaret al.developed a reversed-phase HPLC method for the simultaneous determination of cetirizine and pseudoephedrine in tablets. A Hypersil BDS C18 (5 µm, 25 cm*3.9 mm) column in isocratic mode, with the mobile phase H 2 O/MeCN/Et 3 N (63:37:0.2),was used and the pH was adjusted to 7.5 with 5% phosphoric acid. The flow rate was 1 mL/min. and the effluent was monitored at 254 nm.
13
The objective of this study is to develop and validate an efficient, sensitive, and simple HPLC method with ultraviolet (UV) detection for the simultaneous determination of cetirizine dihydrochloride and pseudoephedrinehydrochloride as a combination in film coated tablet dosage forms.
-190 -sodium heptane sulfonic acid. The pH value was adjusted to 2.5 with sulfuric acid. The flow rate was 1 mL/min at room temperature and the eluent was monitored at a wavelength of 220 nm. The injection volume was 20 µl injected separately for samples, and standards used a back pressure of 10 MPa. The total run time was 9 min.
Reagents and Tools
Pseudoephedrine working standard with a purity of 100% and cetirizine dihydrochloride working standard with a purity of 100% were obtained from Middle East Pharmaceuticals. Tablets of Cirrus(the commercial name of the tablet containing 5 mg cetirizine dihydrochloride and 120 mg pseudoephedrine) were used in the validation solutions. Sodium heptane sulfonic acid reagent grade and sulfuric acid HPLC grade were purchased fromScharlau, Spain. Highly pure water was prepared by using Millipore Millie Q plus purification system.Acetonitrile HPLC grade was obtained from Arcos Lab. Side-tests were performed by UV spectrophotometer,type Beckman-DV-650I, pH meter type Orion-420A, and an analytical balance,type Ohaus. The adjustable pipettesandall glassware used (pipettes, beakers, cylinders, and volumetric flasks) wereof class A grade with high purity and accuracy in measuring volumes.
Standard Preparation
The standard solution of cetirizine dihydrochloride was prepared by dissolving 50 mg of cetirizine dihydrochloride in 50 ml water. Thecetirizine dihydrochloride working solution was prepared from the stock solution by taking 2.5 mL and dilutingup to 100 mL with mobile phase using a volumetric flask. A concentration of 25 µg/mLwas obtained.
The standard solution of pseudoephedrinehydrochloridewas prepared by dissolving 300 mg of pseudoephedrinehydrochloride in 50 ml water. The pseudoephedrinehydrochloride working solution was prepared from the stock solution by taking 10.0 mL and dilutingup to 100 mL with mobile phase using a volumetric flask. A concentration of 600µg/mLwas obtained.
Sample Preparation
The sample solution for cetirizine dihydrochlorideand pseudoephedrinehydrochloridewas prepared by dissolving 1.9 g of Cirrus tablets to be tested in 50 mL water, and then 1.0 mL of the resulting solution was diluted to 20 mL with the mobile phase.
RESULTS AND DISCUSSION

Choice of Detection Wavelength
A UV scan (200.0-300.0nm) was applied for each cetirizine dihydrochloride and pseudoephedrine raw material and samples. Maximum absorbance was observed between 210 and 250 nm. A wavelength of 220 nm was selected as the optimum wavelength for HPLC analysis for both cetirizine dihydrochloride and pseudoephedrine and gave a flat baseline.
Choice of Mobile Phase
The structure, polarity, and solubility of both cetirizine dihydrochloride and pseudoephedrine were investigated. The solubility of the compounds was tested by trying different solvent systems.The initially used mobile phase was acetonitrile: water (550:450 (v/v)), and then changed to acetonitrile: buffer solution (550:450) at pH= 6.0. The ratios of the solvents were changed. Then the sodium heptane sulfonic acid solution was tested with a C 8 column, and the results still were unsatisfactory.
Finally, a mobile phase of amixture of acetonitrile: water (530:470(v/v)) with 200mg/L sodium heptane sulfonic acid was chosen. The pH value was changed from neutral to acidic for improving the separation of these drugs. ThepH of the mobile phase was adjusted to 2.5 by using sulfuric acid at a flow rate of 1 mL/min. The elution time for cetirizine dihydrochloride and pseudoephedrine was 5.4 and 2.9 min, respectively. A C18 column, which provides a minimum noise in the base line,was chosen.
Validation Parameters
The validation of this method was carried out according to ICH and USP guidelines. In this work the method precision, method accuracy, linearity, stability, recovery, robustness, ruggedness, and selectivity parameters were tested.
Method Precision
Standard solutions of 25 and 600µg/mL ofcetirizine dihydrochloride and pseudoephedrine hydrochloride, respectively,wereprepared according to the test method and injected in seven replicates in the chromatograph.
Standard and Sample Precision
System suitability tests are an integral part of a liquid chromatographic method.They were used to verify that the proposed method was able to produce a good resolution between the peaks of interest with high reproducibility. The system suitability was determined by performing seven replicate injections from freshly prepared standard solutions and analyzing each solute for their peak areas. The RSD value of the peak areas was less than 2%. The results of the system suitability test are shown in table 1. According to the results presented, the proposed method fulfills these requirements within the accepted limits (ICH, 2000; USP, 2007; and EP, 2007) .Also, the method's precision of the sample was performed by preparing seven replicate injections, and the RSD value was less than 2%.The results are not shown here. Method Reproducibility (Robustness) Several experimental parameters, like buffer pH, detection wavelength, mobile phase, flow rate and the analyst were varied around the value set in the method to reflect changes likely to arise in different test environments. Analyses were carried out in triplicate and only one parameter was changed in the experiments at a time. The results are shown as a recovery %.
Analysts'Variation
Three more samples were prepared and injected into the chromatograph by another analyst from the same batch. The results are shown in table 2.
Wavelength Variation
Slight variations in wavelength were made to the analytical method in order to evaluate and measure the capacity of the method to remain unaffected by small variations. The wavelength was changed from 220 nm to 225 nm. The results are shown in table 3.
Flow Rate Variation
To study the effect of small changes in the flow rate, it was changed from 1 to 1.2 ml/min. The results are shown in table 4.
PH of the Mobile Phase Variation
When the pH of the mobile phase changed from 2.5 to 2.6, the method gave the same results as shown in table 5.
It is concluded that upon changing the flow rate, the pH of the mobile phase,the wavelength, and the analyst, a slight variation witha RSD% value less than 4.0%appeared on the percentage assay keeping it within the accepted limits. Figure 2(A and B) show the chromatograms of the mentioned variations. The recovery experiments, placebo solution containing cetirizine dihydrochloride standards, showed mean recoveries of 100. The recovery experiments, using a placebo solution containing pseudoephedrinehydrochloride,cetirizine dihydrochloride standards, showed mean recoveries of 100.6 ± 0.7 with R.S.D. values of 0.7% for pseudoephedrine.Results in figure 5 indicate a good recovery value.
Selectivity
The standard, sample, solvent, and placebo solutions were injected into the chromatograph according to the parameters stated under the tested method. It was found that there was no interference between the analytes and both the solvent or placebo,so the method is selectiveand valid for this criteria.
Stability of Solutions
The standard and sample solutions were prepared as stated in the proposed method and they were stored at room temperature. The results are shown in tables 10 and 11. Three more samples were prepared and injected into the chromatograph at0, 24, and 48 hours at room temperature. The results indicate that the method is stable for variation of the time.The RSD value is less than 4.0%. The standard and sample solutions were prepared as stated in the test method and stored in the refrigerator at a temperature of 5 °C. Results are shown in tables 12and 13. Three more samples were prepared and injected into the chromatograph at0, 24, and 48 hours at refrigerator. The results indicate that the method is stable for variation of the time at refrigerator.The RSD value is less than 4.0%. Placebo, standard and production sample solutions were exposed to drastic conditions like heat, 0.1 M HCI, and 0.1 MNaOH to test any degradation products and to study the method for resolving the active component from any degradation products that may be obtained.
Upon exposing the placebo, cetirizine dihydrochloride working standard and the sample solutions to the conditions of pure water, 0.1M HCl, and 0.1MNaOH with heat, it was found that no degradation occurred. Therefore, the proposed method was able to resolve cetirizine dihydrochloride and pseudoephedrine hydrochloride from degradation products, as shown in figure6. 
ANOVA Single Factor Test for CetirizineDihydrochloride Validation Data
The raw data was forced to ANOVA Single Factor statistical analysis to define the significance changes in the data obtained by the proposed method. The P value is the probability, with a value ranging from zero to one. If the P value is small, then the difference between sample means is unlikely to be a coincidence. Instead the populations have different means.Variance within a group is when individual scores within each group vary around the mean of group. SS is the sum of squares between groups or within groups. It is the degree of freedom between and within groups which is used to calculate the mean square (MS) between and within groups.
ANOVA Single Factor Test Method Reproducibility: Variation of the Analysts
When introducing the data obtained by the variation of the analyst (table 2 up) to ANOVA single factor tests, the results in Table 14 were obtained. The data intable14 shows that the P-value is less than 0.05 which indicates that there werenosignificantchanges when the analyst was changed and F 1, 8 Cal (119.73) >F crit (7.71), which means that there was nosignificant difference between the assay of analyst I and the assay of analyst II for method reproducibility.
The variation of other factors (wavelength, flow rate, and pH value) were performed but not shown here. The results were satisfactory.
ANOVA Single Factor Test Stability of Solutions: Storing Sample Solution inRefrigerator
When introducing the data obtained by storage in refrigerator for 0, 24 and 48 hrs (table 12) to ANOVA single factor tests, the results in table 15were obtained. The data intable15 shows that the P-value < 0.05 which indicates that there werenosignificantchanges when analyzing the sample solution atdifferent times and F 2, 6 Cal (20.29) >F crit (9.55), which means that there was nosignificant difference between the assay of a solution at 0 h, 24 h and 48 h when storing the sample solution in arefrigerator for the stability of solutions.
The storing sample solution at room temperature was performed but not shown here. The results were satisfactory. The data in the tableshows that the P-value < 0.05 which indicates that nosignificance changes were observed when analyzing the sample solution atdifferent times and F 2, 6 Cal (13.40) >F crit (9.55), which means that there was nosignificant difference between the assay of solution at 0 h, 24 h and 48 h when storing the sample solution in arefrigerator for the stability of solutions.The storing sample solution at room temperature was performed but not shown here. The results were satisfactory.
ANOVA
CONCLUSION
The proposed method was developed and successfully applied for the simultaneous determination of cetirizine dihydrochloride and pseudoephedrinehydrochloride combined in tablet dosage form. The method development and validation employed an HPLC method with a UV detector.The method was found to be simple, sensitive, and selective. The validation parameters,namely, linearity, accuracy, precision,stability, recovery, and selectivity,wereperformed according to the ICH, USP, and EP guidelines.
Under severe degradation conditions, cetirizine dihydrochloride and pseudoephedrinehydrochloride were found to be stable. The method was found to be rugged and robust. The limit of detection and quantificationfor cetirizine dihydrochloridewere0.805 and2.685 µg/mL,respectively. The limit of detection and quantification for pseudoephedrinehydrochloride were 17.976 and59.921 µg/mL,respectively. The linearity was studied in the concentration range of 12.2 -36.5 µg/mL for cetirizine dihydrochloride and 295.91 -861.73 µg/mLpseudoephedrinehydrochloride.
The results were tested by the ANOVA test and the Pvalue was found to be less than 0.05 which means that the data was not changed upon changing the conditions. Based on the above details,it can be concluded that the method is precise, accurate, and sensitive.In addition, the preparation procedure is simple and the retention timeis short which make it suitable for studying cetirizine dihydrochloride and pseudoephedrinehydrochloride in tablet dosage form combination. 
